What proportion of patients with heart failure and preserved ejection fraction are eligible for empagliflozin?
| Autor: | Monzo L; Department of Cardiology, Policlinico Casilino.; Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University, Rome, RomeItaly., Ferrari I; Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University, Rome, RomeItaly., Cicogna F; Department of Cardiology, Policlinico Casilino., Tota C; Department of Cardiology, Policlinico Casilino., Calò L; Department of Cardiology, Policlinico Casilino. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of cardiovascular medicine (Hagerstown, Md.) [J Cardiovasc Med (Hagerstown)] 2022 Aug 01; Vol. 23 (8), pp. 567-569. |
| DOI: | 10.2459/JCM.0000000000001331 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|